Zayed Mostafa Nasr, Abdelzaher Khaled Mohamed, Mahran Mokhtar Mostafa, Sadek Ahmed Adel
department of otorhinolaryngology, faculty of medicine, El Minia, Egypt.
department of Anaesthesia, faculty of medicine, El Minia, Egypt.
Indian J Otolaryngol Head Neck Surg. 2024 Oct;76(5):4411-4416. doi: 10.1007/s12070-024-04878-3. Epub 2024 Jul 22.
Otosclerosis is one of the most frequent causes of conductive hearing loss in adults. Surgical treatment is considered to be the gold standard for this disease. Endoscopic stapedectomy is a new approach for the treatment of otosclerosis that requires a bloodless field.
To determine whether the routine use of β blockers as a premedication can improve the operative field in endoscopic stapedectomy or not.
Sixty patients aged from 18 to 50 years, undergoing endoscopic stapedectomy, were included in this prospective, randomized, double blinded, placebo-controlled study. Patients were randomly assigned to receive either metoprolol 100 mg ( group 1) or a placebo, vitamin tablet, (group 2) 60 min before surgery.
The age, gender, body weight and ASA physical status were comparable between the two groups. The average blood loss in the placebo group was significantly greater than in the metoprolol group, but the time of operation in the metoprolol group was not significantly shorter. The surgical field was assessed using the Fromme-Boezaart scale, and those who received metoprolol had considerably cleaner (p0.001) surgical fields. The mean arterial pressure (MAP) didn't differ statistically significant at basal measurement up to 30 min after anesthesia induction while it was significantly lower in the metoprolol group after 30 min of induction up to end of surgery ( < 0.001). The heart rate was also significantly lower ( < 0.001) in patients who received metoprolol from prior to anesthesia induction up to end of surgery.
metoprolol significantly improves visual clarity and hemodynamics during endoscopic stapedectomy.
耳硬化症是成人传导性听力损失最常见的病因之一。手术治疗被认为是该病的金标准。内镜下镫骨切除术是一种治疗耳硬化症的新方法,需要无血手术视野。
确定常规使用β受体阻滞剂作为术前用药是否能改善内镜下镫骨切除术的手术视野。
本前瞻性、随机、双盲、安慰剂对照研究纳入了60例年龄在18至50岁之间接受内镜下镫骨切除术的患者。患者在手术前60分钟被随机分配接受100毫克美托洛尔(第1组)或安慰剂(维生素片,第2组)。
两组患者的年龄、性别、体重和美国麻醉医师协会(ASA)身体状况相当。安慰剂组的平均失血量明显大于美托洛尔组,但美托洛尔组的手术时间没有明显缩短。使用弗罗梅-博扎尔特量表评估手术视野,接受美托洛尔的患者手术视野明显更清洁(p<0.001)。基础测量时直至麻醉诱导后30分钟,平均动脉压(MAP)在统计学上无显著差异,而诱导30分钟后直至手术结束,美托洛尔组的MAP显著更低(p<0.001)。从麻醉诱导前直至手术结束,接受美托洛尔的患者心率也显著更低(p<0.001)。
美托洛尔可显著改善内镜下镫骨切除术期间的视野清晰度和血流动力学。